Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Daypro alta, 174064-08-5, Oxaprozin (potassium), Ml56o2z92i, Unii-ml56o2z92i, Oxaprozin, potassium salt

Molecular Formula

C₁₈H₁₄KNO₃

Molecular Weight

331.4 g/mol

InChI Key

QTAQWNSMRSLSCG-UHFFFAOYSA-M

FDA UNII

ML56O2Z92I

Oxaprozin Potassium is the potassium salt form of oxaprozin and a member of the propionic acid group of non-steroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory, analgesic and antipyretic properties. Oxaprozin potassium reversibly and competitively inhibits cyclooxygenases (COX), thereby blocking the conversion of arachidonic acid to pro-inflammatory prostaglandins. This inhibits the formation of prostaglandins that are involved in pain, inflammation and fever.

1 2D Structure

Oxaprozin Potassium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

potassium;3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoate

2.1.2 InChI

InChI=1S/C18H15NO3.K/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14;/h1-10H,11-12H2,(H,20,21);/q;+1/p-1

2.1.3 InChI Key

QTAQWNSMRSLSCG-UHFFFAOYSA-M

2.1.4 Canonical SMILES

C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)[O-])C3=CC=CC=C3.[K+]

2.2 Other Identifiers

2.2.1 UNII

ML56O2Z92I

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Daypro Alta

2. 174064-08-5

3. Oxaprozin (potassium)

4. Ml56o2z92i

5. Unii-ml56o2z92i

6. Oxaprozin, Potassium Salt

7. Schembl8190699

8. 2-oxazolepropanoic Acid, 4,5-diphenyl-, Potassium Salt

9. Chembl1200463

10. Hy-b0808a

11. Dtxsid70169754

12. Oxaprozin Potassium [mart.]

13. Oxaprozin Potassium [who-dd]

14. Oxaprozin Potassium [orange Book]

15. Cs-0031253

16. Q27284098

17. Potassium;3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoate

2.4 Create Date

2008-02-05

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₄KNO₃
Molecular Weight	331.4 g/mol
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	5
Exact Mass	331.06107479 g/mol
Monoisotopic Mass	331.06107479 g/mol
Topological Polar Surface Area	66.2 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	367
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2